GSK PLC to Release Quarterly Earnings on July 30, 2025
GSK PLC, a leading pharmaceutical company, will release its quarterly earnings on July 30, 2025. Analysts expect a decline in earnings per share compared to the same period last year, with a projected decrease of an unspecified amount.
Revenue and Stock Performance
According to analyst forecasts, revenue is expected to increase slightly compared to the same period last year. The company’s stock price has experienced fluctuations in recent days, with no specific pattern or trend identified.
Partnership with Hengrui Pharma
GSK PLC has entered into a partnership with Chinese firm Hengrui Pharma to develop up to 12 new medicines across various therapeutic areas. The deal, worth $500 million, is expected to drive growth for GSK beyond 2031.
Key Details of the Partnership
- Value: $500 million
- Scope: Development of up to 12 new medicines across various therapeutic areas
- Expected impact: Drive growth for GSK beyond 2031
The partnership has led to a surge in Hengrui Pharma’s stock price, while GSK’s shares have also gained ground.